loadpatents
Patent applications and USPTO patent grants for Flanner; Henry H..The latest application filed is for "process for preparing an e-selectin inhibitor intermediate".
Patent | Date |
---|---|
Process For Preparing An E-selectin Inhibitor Intermediate App 20220289784 - Flanner; Henry H. ;   et al. | 2022-09-15 |
Methods For Treating Acute Myeloid Leukemia And Related Conditions App 20210069220 - THACKRAY; Helen M. ;   et al. | 2021-03-11 |
Antibiotic product, use and formulation thereof Grant 9,144,548 - Burnside , et al. September 29, 2 | 2015-09-29 |
Gastric release pulse system for drug delivery Grant 9,125,803 - Flanner , et al. September 8, 2 | 2015-09-08 |
Modified release amoxicillin products Grant 8,778,924 - Flanner , et al. July 15, 2 | 2014-07-15 |
Antibiotic product, use and formulation thereof Grant 8,460,710 - Burnside , et al. June 11, 2 | 2013-06-11 |
Antibiotic product, use and formulation thereof Grant 8,425,936 - Burnside , et al. April 23, 2 | 2013-04-23 |
Once Daily Trospium Chloride Treatment Method App 20130089607 - KIDANE; Argaw ;   et al. | 2013-04-11 |
Compositions and methods for improved efficacy of penicillin-type antibiotics Grant 8,357,394 - Flanner , et al. January 22, 2 | 2013-01-22 |
Antibiotic product, use and formulation thereof Grant 8,313,775 - Burnside , et al. November 20, 2 | 2012-11-20 |
Antibiotic product, use and formulation thereof Grant 8,313,776 - Burnside , et al. November 20, 2 | 2012-11-20 |
Pharmaceutical compositions and methods for improved bacterial eradication Grant 8,299,052 - Flanner , et al. October 30, 2 | 2012-10-30 |
Antibiotic Product, Use And Formulation Thereof App 20120213825 - Burnside; Beth A. ;   et al. | 2012-08-23 |
Antibiotic product, use and formulation thereof Grant 8,246,996 - Burnside , et al. August 21, 2 | 2012-08-21 |
Antibiotic product, use and formulation thereof Grant 8,062,672 - Burnside , et al. November 22, 2 | 2011-11-22 |
Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration App 20100222375 - KIDANE; Argaw ;   et al. | 2010-09-02 |
Pharmaceutical Composition For Once-a-day Oral Administration Of Trospium Chloride App 20100221354 - Kidane; Argaw ;   et al. | 2010-09-02 |
Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride App 20100221353 - KIDANE; Argaw ;   et al. | 2010-09-02 |
Pharmaceutical Composition For Once A Day Administration Of Trospium Chloride App 20100221356 - KIDANE; Argaw ;   et al. | 2010-09-02 |
Pharmaceutical Composition For Once-a-day Oral Administration Of Trospium Chloride App 20100221355 - KIDANE; Argaw ;   et al. | 2010-09-02 |
Pharmaceutical Composition For The Once-a-day Oral Administration Of Trospium Chloride App 20100221352 - KIDANE; Argaw ;   et al. | 2010-09-02 |
Trospium chloride treatment method Grant 7,781,449 - Kidane , et al. August 24, 2 | 2010-08-24 |
Once daily dosage forms of trospium Grant 7,781,448 - Kidane , et al. August 24, 2 | 2010-08-24 |
Once daily dosage forms of trospium Grant 7,763,635 - Kidane , et al. July 27, 2 | 2010-07-27 |
Method of treating bladder dysfunction with once-a-day trospium salt formulation Grant 7,759,359 - Kidane , et al. July 20, 2 | 2010-07-20 |
Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus App 20100120896 - Sander; Sanna ;   et al. | 2010-05-13 |
Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureus App 20100016333 - Flanner; Henry H. ;   et al. | 2010-01-21 |
Once daily dosage forms of trospium App 20080207661 - Kidane; Argaw ;   et al. | 2008-08-28 |
Once daily dosage forms of trospium App 20080207664 - Kidane; Argaw ;   et al. | 2008-08-28 |
Once daily dosage forms of trospium App 20080207662 - Kidane; Argaw ;   et al. | 2008-08-28 |
Once daily dosage forms of trospium App 20080207663 - Kidane; Argaw ;   et al. | 2008-08-28 |
Once daily dosage forms of trospium Grant 7,410,978 - Kidane , et al. August 12, 2 | 2008-08-12 |
Modified release dosage forms of amoxicillin App 20080139526 - Treacy; Donald ;   et al. | 2008-06-12 |
Modified release amoxicillin products App 20080132478 - Flanner; Henry H. ;   et al. | 2008-06-05 |
Pharmaceutical compositions and methods for improved bacterial eradication App 20080050430 - Flanner; Henry H. ;   et al. | 2008-02-28 |
Gastric release pulse system for drug delivery App 20070154547 - Flanner; Henry H. ;   et al. | 2007-07-05 |
Compositions and methods for improved efficacy of penicillin-type antibiotics App 20070134327 - Flanner; Henry H. ;   et al. | 2007-06-14 |
Pharmaceutical Tablet And Apparatus And Method For Making App 20060222705 - Flanner; Henry H. ;   et al. | 2006-10-05 |
Once daily dosage forms of trospium App 20050191351 - Kidane, Argaw ;   et al. | 2005-09-01 |
Enhanced absorption of modified release dosage forms App 20050142187 - Treacy, Donald J. JR. ;   et al. | 2005-06-30 |
Antibiotic product, use and formulation thereof App 20050058708 - Burnside, Beth A. ;   et al. | 2005-03-17 |
Antibiotic product, use and formulation thereof App 20050048114 - Burnside, Beth A. ;   et al. | 2005-03-03 |
Antibiotic product, use and formulation thereof App 20050037076 - Burnside, Beth A. ;   et al. | 2005-02-17 |
Antibiotic product, use and formulation thereof App 20050019401 - Burnside, Beth A. ;   et al. | 2005-01-27 |
Antibiotic product, use and formulation thereof App 20050019403 - Burnside, Beth A. ;   et al. | 2005-01-27 |
Antibiotic product, use and formulation thereof App 20050019402 - Burnside, Beth A. ;   et al. | 2005-01-27 |
System for osmotic delivery of pharmaceutically active agents Grant 6,838,093 - Flanner , et al. January 4, 2 | 2005-01-04 |
Osmotic drug delivery system Grant 6,814,979 - Rudnic , et al. November 9, 2 | 2004-11-09 |
Pharmaceutical formulations with improved bioavailability App 20040028729 - Shojaei, Amir H. ;   et al. | 2004-02-12 |
Soluble form osmotic dose delivery system App 20030143273 - Rudnic, Edward M. ;   et al. | 2003-07-31 |
Soluble form osmotic dose delivery system Grant 6,514,532 - Rudnic , et al. February 4, 2 | 2003-02-04 |
System for osmotic delivery of pharmaceutically active agents App 20030003150 - Burnside, Beth A. ;   et al. | 2003-01-02 |
Soluble form osmotic dose delivery system App 20020102306 - Rudnic, Edward M. ;   et al. | 2002-08-01 |
Rapid immediate release oral dosage form Grant 6,384,020 - Flanner , et al. May 7, 2 | 2002-05-07 |
Soluble form osmotic dose delivery system Grant 6,361,796 - Rudnic , et al. March 26, 2 | 2002-03-26 |
Soluble form osmotic dose delivery system Grant 6,284,276 - Rudnic , et al. September 4, 2 | 2001-09-04 |
Osmotic drug delivery system Grant 6,110,498 - Rudnic , et al. August 29, 2 | 2000-08-29 |
NCAGE Code | 4C0A4 | FLANNER HENRY H |
CAGE Code | 4C0A4 | FLANNER, HENRY H |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.